Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 143 to 192 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANLN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
anillin, actin binding protein (scraps homolog, drosophila); anillin (drosophila scraps homolog), actin binding protein. [source:refseq;acc:nm\_018685]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20408\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNIP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kv channel interacting protein 1; vesicle apc-binding protein; a-type potassium channel modulatory protein 1. [source:refseq;acc:nm\_014592]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNIP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium channel-interacting protein 4 isoform 4; calsenilin-like protein. [source:refseq;acc:nm\_147183]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20293\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNIP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.531\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20291\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
50.7983\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
42.3003\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2009\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UNC84A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
296.677\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
247.559\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
150\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYO5B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
55\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
46\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.19565\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
151\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYO5C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
152\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM15B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromosome 3p21.1 gene sequence. [source:refseq;acc:nm\_013286]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.19466\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGS19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of g-protein signaling 19 (rgs19) (g-alpha interacting protein) (gaip protein). [source:swissprot;acc:p49795]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
155\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGS20\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of g-protein signaling 20 (rgs20) (regulator of gz- selective protein signaling 1) (gz-selective gtpase-activating protein) (g(z)gap). [source:swissprot;acc:o76081]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LBX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor lbx1. [source:swissprot;acc:p52954]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GPSM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mosaic protein lgn. [source:swissprot;acc:p81274]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGS17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of g-protein signaling 17 (rgs17). [source:swissprot;acc:q9ugc6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNAO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(o), alpha subunit 1. [source:swissprot;acc:p09471]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
161\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAP1GAP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rap1 gtpase-activating protein 1 (rap1gap). [source:swissprot;acc:p47736]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOSTRIN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nostrin. [source:refseq;acc:nm\_052946]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.299\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
249.187\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.19058\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNF8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eap30 subunit of ell complex. [source:refseq;acc:nm\_007241]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
164\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC39A6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
liv-1 protein, estrogen regulated. [source:refseq;acc:nm\_012319]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
165\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NAPG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamate decarboxylase, 67 kda isoform (ec 4.1.1.15) (gad-67) (67 kda glutamic acid decarboxylase). [source:swissprot;acc:q99259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
168\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
82.5916\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
98.0548\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.18722\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
169\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
170\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TIA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolysin tia-1 (rna-binding protein tia-1) (p40-tia-1) [contains: p15-tia-1]. [source:swissprot;acc:p31483]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.199\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.715\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17894\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
171\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TIAL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolysin tiar (tia-1 related protein). [source:swissprot;acc:q01085]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.202\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17829\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TIPRL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cg9578-like; yeast ypr037w and worm c02c2.6 predicted proteins-like. [source:refseq;acc:nm\_152902]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
174.667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.556\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17685\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
173\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRPD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.032\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.056\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17599\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
174\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DGCR14\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
286\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17133\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COPS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cop9 constitutive photomorphogenic homolog subunit 3; cop9 complex subunit 3; jab1-containing signalosome subunit 3. [source:refseq;acc:nm\_003653]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.949\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.187\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.17123\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLE4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna polymerase epsilon p12 subunit (dna polymerase epsilon subunit 4). [source:swissprot;acc:q9nr33]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
275.754\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.908\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NCBP2L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj820b18.1 (similar to nuclear cap binding protein) (fragment). [source:sptrembl;acc:q8wwk2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
196.695\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1663\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
178\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
formin binding protein 3; fas-ligand associated factor 1; huntingtin-interacting protein a; ny-ren-6 antigen. [source:refseq;acc:nm\_017892]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.887\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1652\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
179\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
huntingtin-interacting protein hypa/fbp11 (fragment). [source:sptrembl;acc:o75404]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16476\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TARDBP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tar dna-binding protein-43 (tdp-43). [source:swissprot;acc:q13148]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
256.228\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
298.438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
B9D1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
b9 protein; likely ortholog of mouse endothelial precursor protein b9. [source:refseq;acc:nm\_015681]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.818\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.16294\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone acetyltransferase type b catalytic subunit (ec 2.3.1.48). [source:swissprot;acc:o14929]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
277.546\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.461\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NCBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.306\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.011\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
odd-skipped related 1; odz (odd oz/ten-m) related 1. [source:refseq;acc:nm\_145260]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
274.027\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15239\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADIPOR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adiponectin receptor 2. [source:refseq;acc:nm\_024551]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
281.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
246.371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14292\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FLNB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
filamin b, beta (actin binding protein 278); beta filamin; filamin 1 (actin-binding protein-280)-like; filamin b, beta (actin-binding protein-278); filamin b, beta. [source:refseq;acc:nm\_001457]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.582\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
198.444\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14179\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REV1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rev1-like; rev1 protein; rev1 (yeast homolog)- like. [source:refseq;acc:nm\_016316]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRMT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein arginine n-methyltransferase 1 (ec 2.1.1.-) (interferon receptor 1-bound protein 4). [source:swissprot;acc:q99873]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRMT8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein arginine n-methyltransferase 4 (ec 2.1.1.-). [source:swissprot;acc:q9nr22]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRP70\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
u1 small nuclear ribonucleoprotein 70 kda (u1 snrnp 70 kda) (snrnp70) (u1-70k). [source:swissprot;acc:p08621]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
filamin a (alpha-filamin) (filamin 1) (endothelial actin-binding protein) (abp-280) (nonmuscle filamin). [source:swissprot;acc:p21333]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MSI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
musashi 2 isoform a. [source:refseq;acc:nm\_138962]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.491\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.458\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14055\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/